ClinVar Miner

Submissions for variant NM_020975.6(RET):c.1083C>A (p.Asn361Lys) (rs770587835)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000663048 SCV000786098 uncertain significance Multiple endocrine neoplasia, type 2a 2018-02-21 criteria provided, single submitter clinical testing
Invitae RCV000823028 SCV000963866 uncertain significance Multiple endocrine neoplasia, type 2 2018-09-19 criteria provided, single submitter clinical testing This sequence change replaces asparagine with lysine at codon 361 of the RET protein (p.Asn361Lys). The asparagine residue is weakly conserved and there is a moderate physicochemical difference between asparagine and lysine. This variant is not present in population databases (ExAC no frequency). This missense change has been observed in an individual affected with Hirschsprung disease (PMID: 10790203). ClinVar contains an entry for this variant (Variation ID: 548864). Experimental studies have shown that this missense change affects RET protein folding and cellular localization (PMID: 12915470, 26517685). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.